Global and China Digital Companion Diagnostics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Polymerase Chain Reaction (PCR)
1.2.3 Immunohistochemistry (IHC)
1.2.4 In Situ Hybridization (ISH)
1.2.5 Next Generation Sequencing (NGS)
1.3 Market by Application
1.3.1 Global Digital Companion Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Digital Companion Diagnostics Market Perspective (2015-2026)
2.2 Global Digital Companion Diagnostics Growth Trends by Regions
2.2.1 Digital Companion Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Digital Companion Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Digital Companion Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Digital Companion Diagnostics Players by Market Size
3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Digital Companion Diagnostics Revenue
3.4 Global Digital Companion Diagnostics Market Concentration Ratio
3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2019
3.5 Key Players Digital Companion Diagnostics Area Served
3.6 Key Players Digital Companion Diagnostics Product Solution and Service
3.7 Date of Enter into Digital Companion Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Companion Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2021-2026)
5 Digital Companion Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Digital Companion Diagnostics Market Size (2015-2026)
6.2 North America Digital Companion Diagnostics Market Size by Type (2015-2020)
6.3 North America Digital Companion Diagnostics Market Size by Application (2015-2020)
6.4 North America Digital Companion Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Digital Companion Diagnostics Market Size (2015-2026)
7.2 Europe Digital Companion Diagnostics Market Size by Type (2015-2020)
7.3 Europe Digital Companion Diagnostics Market Size by Application (2015-2020)
7.4 Europe Digital Companion Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Digital Companion Diagnostics Market Size (2015-2026)
8.2 China Digital Companion Diagnostics Market Size by Type (2015-2020)
8.3 China Digital Companion Diagnostics Market Size by Application (2015-2020)
8.4 China Digital Companion Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Digital Companion Diagnostics Market Size (2015-2026)
9.2 Japan Digital Companion Diagnostics Market Size by Type (2015-2020)
9.3 Japan Digital Companion Diagnostics Market Size by Application (2015-2020)
9.4 Japan Digital Companion Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Digital Companion Diagnostics Market Size (2015-2026)
10.2 Southeast Asia Digital Companion Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia Digital Companion Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia Digital Companion Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Roche Holdings (Switzerland)
11.1.1 Roche Holdings (Switzerland) Company Details
11.1.2 Roche Holdings (Switzerland) Business Overview
11.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Introduction
11.1.4 Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2015-2020))
11.1.5 Roche Holdings (Switzerland) Recent Development
11.2 Abbott Laboratories (US)
11.2.1 Abbott Laboratories (US) Company Details
11.2.2 Abbott Laboratories (US) Business Overview
11.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Introduction
11.2.4 Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.2.5 Abbott Laboratories (US) Recent Development
11.3 Thermo Fisher Scientific (US)
11.3.1 Thermo Fisher Scientific (US) Company Details
11.3.2 Thermo Fisher Scientific (US) Business Overview
11.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Introduction
11.3.4 Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.3.5 Thermo Fisher Scientific (US) Recent Development
11.4 Agilent Technologies (US)
11.4.1 Agilent Technologies (US) Company Details
11.4.2 Agilent Technologies (US) Business Overview
11.4.3 Agilent Technologies (US) Digital Companion Diagnostics Introduction
11.4.4 Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.4.5 Agilent Technologies (US) Recent Development
11.5 Life Technologies (US)
11.5.1 Life Technologies (US) Company Details
11.5.2 Life Technologies (US) Business Overview
11.5.3 Life Technologies (US) Digital Companion Diagnostics Introduction
11.5.4 Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.5.5 Life Technologies (US) Recent Development
11.6 GE Healthcare (UK)
11.6.1 GE Healthcare (UK) Company Details
11.6.2 GE Healthcare (UK) Business Overview
11.6.3 GE Healthcare (UK) Digital Companion Diagnostics Introduction
11.6.4 GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.6.5 GE Healthcare (UK) Recent Development
11.7 Agendia (Angola)
11.7.1 Agendia (Angola) Company Details
11.7.2 Agendia (Angola) Business Overview
11.7.3 Agendia (Angola) Digital Companion Diagnostics Introduction
11.7.4 Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.7.5 Agendia (Angola) Recent Development
11.8 Qiagen (Germany)
11.8.1 Qiagen (Germany) Company Details
11.8.2 Qiagen (Germany) Business Overview
11.8.3 Qiagen (Germany) Digital Companion Diagnostics Introduction
11.8.4 Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.8.5 Qiagen (Germany) Recent Development
11.9 Genomic Health (US)
11.9.1 Genomic Health (US) Company Details
11.9.2 Genomic Health (US) Business Overview
11.9.3 Genomic Health (US) Digital Companion Diagnostics Introduction
11.9.4 Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.9.5 Genomic Health (US) Recent Development
11.10 Myriad Genetics (US)
11.10.1 Myriad Genetics (US) Company Details
11.10.2 Myriad Genetics (US) Business Overview
11.10.3 Myriad Genetics (US) Digital Companion Diagnostics Introduction
11.10.4 Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
11.10.5 Myriad Genetics (US) Recent Development
11.11 Advanced Cell Diagnostics (US)
10.11.1 Advanced Cell Diagnostics (US) Company Details
10.11.2 Advanced Cell Diagnostics (US) Business Overview
10.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Introduction
10.11.4 Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
10.11.5 Advanced Cell Diagnostics (US) Recent Development
11.12 Danaher (US)
10.12.1 Danaher (US) Company Details
10.12.2 Danaher (US) Business Overview
10.12.3 Danaher (US) Digital Companion Diagnostics Introduction
10.12.4 Danaher (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
10.12.5 Danaher (US) Recent Development
11.13 Applied Proteomics (US)
10.13.1 Applied Proteomics (US) Company Details
10.13.2 Applied Proteomics (US) Business Overview
10.13.3 Applied Proteomics (US) Digital Companion Diagnostics Introduction
10.13.4 Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2015-2020)
10.13.5 Applied Proteomics (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In Situ Hybridization (ISH)
Table 6. Key Players of Next Generation Sequencing (NGS)
Table 7. Global Digital Companion Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Digital Companion Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Digital Companion Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Digital Companion Diagnostics Market Share by Regions (2015-2020)
Table 11. Global Digital Companion Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Digital Companion Diagnostics Market Share by Regions (2021-2026)
Table 13. Digital Companion Diagnostics Market Market Trends
Table 14. Digital Companion Diagnostics Market Drivers
Table 15. Digital Companion Diagnostics Market Challenges
Table 16. Digital Companion Diagnostics Market Restraints
Table 17. Global Digital Companion Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Digital Companion Diagnostics Market Share by Players (2015-2020)
Table 19. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2019)
Table 20. Global Digital Companion Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Digital Companion Diagnostics Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Digital Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Digital Companion Diagnostics Market Size Share by Type (2015-2020)
Table 26. Global Digital Companion Diagnostics Revenue Market Share by Type (2021-2026)
Table 27. Global Digital Companion Diagnostics Market Size Share by Application (2015-2020)
Table 28. Global Digital Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Digital Companion Diagnostics Market Size Share by Application (2021-2026)
Table 30. North America Digital Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 32. North America Digital Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 34. North America Digital Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Digital Companion Diagnostics Market Share by Country (2015-2020)
Table 36. Europe Digital Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 38. Europe Digital Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 40. Europe Digital Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Digital Companion Diagnostics Market Share by Country (2015-2020)
Table 42. China Digital Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 43. China Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 44. China Digital Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 45. China Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 46. China Digital Companion Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 47. China Digital Companion Diagnostics Market Share by Region (2015-2020)
Table 48. Japan Digital Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 50. Japan Digital Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 52. Japan Digital Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Digital Companion Diagnostics Market Share by Country (2015-2020)
Table 54. Southeast Asia Digital Companion Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Digital Companion Diagnostics Market Share by Type (2015-2020)
Table 56. Southeast Asia Digital Companion Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Digital Companion Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia Digital Companion Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Digital Companion Diagnostics Market Share by Country (2015-2020)
Table 60. Roche Holdings (Switzerland) Company Details
Table 61. Roche Holdings (Switzerland) Business Overview
Table 62. Roche Holdings (Switzerland) Product
Table 63. Roche Holdings (Switzerland) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 64. Roche Holdings (Switzerland) Recent Development
Table 65. Abbott Laboratories (US) Company Details
Table 66. Abbott Laboratories (US) Business Overview
Table 67. Abbott Laboratories (US) Product
Table 68. Abbott Laboratories (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 69. Abbott Laboratories (US) Recent Development
Table 70. Thermo Fisher Scientific (US) Company Details
Table 71. Thermo Fisher Scientific (US) Business Overview
Table 72. Thermo Fisher Scientific (US) Product
Table 73. Thermo Fisher Scientific (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 74. Thermo Fisher Scientific (US) Recent Development
Table 75. Agilent Technologies (US) Company Details
Table 76. Agilent Technologies (US) Business Overview
Table 77. Agilent Technologies (US) Product
Table 78. Agilent Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 79. Agilent Technologies (US) Recent Development
Table 80. Life Technologies (US) Company Details
Table 81. Life Technologies (US) Business Overview
Table 82. Life Technologies (US) Product
Table 83. Life Technologies (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 84. Life Technologies (US) Recent Development
Table 85. GE Healthcare (UK) Company Details
Table 86. GE Healthcare (UK) Business Overview
Table 87. GE Healthcare (UK) Product
Table 88. GE Healthcare (UK) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 89. GE Healthcare (UK) Recent Development
Table 90. Agendia (Angola) Company Details
Table 91. Agendia (Angola) Business Overview
Table 92. Agendia (Angola) Product
Table 93. Agendia (Angola) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 94. Agendia (Angola) Recent Development
Table 95. Qiagen (Germany) Business Overview
Table 96. Qiagen (Germany) Product
Table 97. Qiagen (Germany) Company Details
Table 98. Qiagen (Germany) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 99. Qiagen (Germany) Recent Development
Table 100. Genomic Health (US) Company Details
Table 101. Genomic Health (US) Business Overview
Table 102. Genomic Health (US) Product
Table 103. Genomic Health (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 104. Genomic Health (US) Recent Development
Table 105. Myriad Genetics (US) Company Details
Table 106. Myriad Genetics (US) Business Overview
Table 107. Myriad Genetics (US) Product
Table 108. Myriad Genetics (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 109. Myriad Genetics (US) Recent Development
Table 110. Advanced Cell Diagnostics (US) Company Details
Table 111. Advanced Cell Diagnostics (US) Business Overview
Table 112. Advanced Cell Diagnostics (US) Product
Table 113. Advanced Cell Diagnostics (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 114. Advanced Cell Diagnostics (US) Recent Development
Table 115. Danaher (US) Company Details
Table 116. Danaher (US) Business Overview
Table 117. Danaher (US) Product
Table 118. Danaher (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 119. Danaher (US) Recent Development
Table 120. Applied Proteomics (US) Company Details
Table 121. Applied Proteomics (US) Business Overview
Table 122. Applied Proteomics (US) Product
Table 123. Applied Proteomics (US) Revenue in Digital Companion Diagnostics Business (2015-2020) (US$ Million)
Table 124. Applied Proteomics (US) Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Digital Companion Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Polymerase Chain Reaction (PCR) Features
Figure 3. Immunohistochemistry (IHC) Features
Figure 4. In Situ Hybridization (ISH) Features
Figure 5. Next Generation Sequencing (NGS) Features
Figure 6. Global Digital Companion Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Other Case Studies
Figure 11. Digital Companion Diagnostics Report Years Considered
Figure 12. Global Digital Companion Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Digital Companion Diagnostics Market Share by Regions: 2020 VS 2026
Figure 14. Global Digital Companion Diagnostics Market Share by Regions (2021-2026)
Figure 15. Global Digital Companion Diagnostics Market Share by Players in 2019
Figure 16. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Digital Companion Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2019
Figure 18. North America Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Digital Companion Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Roche Holdings (Switzerland) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 46. Abbott Laboratories (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 47. Thermo Fisher Scientific (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 48. Agilent Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 49. Life Technologies (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 50. GE Healthcare (UK) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 51. Agendia (Angola) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 52. Qiagen (Germany) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 53. Genomic Health (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 54. Myriad Genetics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 55. Advanced Cell Diagnostics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 56. Danaher (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 57. Applied Proteomics (US) Revenue Growth Rate in Digital Companion Diagnostics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed